Hagerty, Inc. Form 8-K Summary
Business Context and Reporting Period
Hagerty, Inc. reported an event involving its subsidiary, Hagerty Insurance Holdings, Inc. The Stock Purchase Agreement was entered into on January 12, 2024; the filing was signed and submitted on February 12, 2024. No quarterly or annual financial results are reported.
Transaction and Key Financial Terms
- Hagerty Insurance Holdings agreed to acquire all outstanding shares of Consolidated National Insurance Company (CNIC) from Everspan Insurance Company.
- The purchase price is approximately $18.4 million, subject to adjustment under the agreement.
- The price consists of approximately $10 million for approved state licenses and $8 million for expected capital and surplus.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or per-share financial metrics for the period.
Strategic Rationale and Expected Timing
CNIC is intended to serve as Hagerty’s carrier platform, enabling a direct underwriting carrier model. Hagerty expects the platform to help retain more underwriting profit, reduce frictional costs for customers, and support new products and coverage offerings in the underserved classic and enthusiast vehicle market.
Closing is subject to customary conditions, including regulatory approval from the Colorado Division of Insurance. The company stated that its approval request was filed on February 12, 2024, and that closing was expected in the second quarter of 2024, subject to satisfactory completion of the closing conditions.
Material Changes, Risks, and Unusual Items
- The proposed acquisition represents a material change in Hagerty’s operating model through potential ownership and control of an insurance carrier.
- The transaction remained subject to regulatory approval and other closing conditions; completion was not assured.
- Identified risks include delayed or unavailable regulatory approval, failure to satisfy closing conditions, termination of the agreement, transaction-related uncertainty, management distraction, unexpected costs, litigation, and regulatory actions.
- The stated purchase price and closing date are forward-looking and may change.
- The filing does not provide a quantified impact on future revenue, earnings, cash flow, capital requirements, or liquidity.
Investor Verification Checklist
- Verify whether the transaction closed in the expected second quarter of 2024 and the final purchase price paid.
- Confirm regulatory approval status and the terms of any required capital and surplus funding.
- Assess the effect of CNIC ownership on underwriting profitability, written premiums, retention, and operating expenses.
- Review subsequent SEC filings for transaction accounting, liquidity effects, insurance regulatory requirements, and any litigation or termination developments.
- Review the attached investor presentation and subsequent filings for additional product, market, and financial guidance.